Cathelicidin (hCAP-18 / Synthetic Derivatives) Protocol — Complete Dosing & Administration Guide

Dosing

How muchdo I take?

Topical: Applied onto the skin as a cream, gel, or lotion — it works mainly where you put it.

Bioavailability Local — acts mainly at the skin; little reaches the bloodstream.

Standard Dose

0.5 mg/mL drops (about 100 microliters per application)

Frequency

Twice daily

Duration

2 weeks

In a human phase 2a ear study, OP-145 drops at 0.5 mg per mL were applied to the affected ear twice daily for 2 weeks and were safe and well tolerated [4].

Timing

Best time to take

Apply Cathelicidin (hCAP-18 / Synthetic Derivatives) to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.

With food?

As a topical product, Cathelicidin (hCAP-18 / Synthetic Derivatives) is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.

If stacking

Cathelicidin (hCAP-18 / Synthetic Derivatives) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

+You've tolerated the current dose for the recommended period without significant side effects

+Therapeutic goals haven't been met at the current dose level

+Your healthcare provider recommends dose escalation based on your response

+Lab work or clinical assessments support a higher dose

Decrease if

-Side effects are bothersome or impacting daily life despite management strategies

-You experience any signs of an adverse reaction

-Lab results indicate the need for dose reduction

-Your healthcare provider recommends a lower dose based on your response

Signs of right dose

✓Therapeutic goals being met with minimal side effects

✓Stable and consistent response to treatment

✓Lab values or clinical markers trending in the right direction

✓Good tolerance with manageable or absent side effects

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do Iuse it?

Reconstitution

What you need

•Cathelicidin (hCAP-18 / Synthetic Derivatives) in its prescribed form

•Clean, dry storage container

•Measuring device if applicable (oral syringe, measuring cup)

•Calendar or reminder app for dosing schedule

Example

Cathelicidin (hCAP-18 / Synthetic Derivatives) comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Use Cathelicidin (hCAP-18 / Synthetic Derivatives) exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Injection

Route

Cathelicidin (hCAP-18 / Synthetic Derivatives) is administered Topical application (primary research route)—no injection required

Best sites

•Not applicable—this is not an injectable formulation

Technique

1.Follow the specific administration instructions for your Cathelicidin (hCAP-18 / Synthetic Derivatives) formulation

2.Take or apply as directed by your healthcare provider

3.Store properly between uses according to package instructions

Storage

Before reconstitution

Store Cathelicidin (hCAP-18 / Synthetic Derivatives) in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Cathelicidin (hCAP-18 / Synthetic Derivatives) should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

Solution appears cloudy, discolored, or contains visible particles (should be clear)

Product has been exposed to temperatures outside the recommended storage range

Product has been frozen (unless specifically designed for freeze-thaw stability)

Expiration date has passed or reconstituted solution has exceeded its use-by date

Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (once daily)

As prescribed by your healthcare provider injection

Site: Topical application (primary research route)—rotate sites if applicable

Maintain a consistent schedule for optimal results with Cathelicidin (hCAP-18 / Synthetic Derivatives). Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is itsafe?

Safety Profile

Cathelicidin peptides (natural and synthetic) are not FDA-approved and have no completed human clinical trials. Animal studies demonstrate broad-spectrum antimicrobial activity without systemic toxicity at therapeutic concentrations. However, concern exists regarding immunological tolerance—cathelicidin derivatives can trigger innate immune activation and inflammatory responses at high concentrations. The peptide's mechanism on immune cells is incompletely understood in humans, and effects on chronic immune signaling, tolerance development, or off-target immune activation remain uncharacterized. Bacterial resistance development to cathelicidin-based therapeutics is theoretically possible but not yet documented clinically.

Evidence is limited to in vitro antimicrobial activity assays, animal infection models, and preclinical immune cell studies. No human pharmacokinetics, dose-escalation studies, Phase 1 safety data, or clinical efficacy trials exist. Published research focuses on mechanism of antimicrobial action rather than safety profiling or tolerability in human use.

Common Side Effects

Experienced by some users

Local application site irritation

Mild redness, warmth, and stinging at the topical application site. Reflects the peptide's interaction with skin cells and local immune activation.

Management: Use appropriate formulation vehicle (hypromellose ointment). Apply to wound bed rather than intact skin. Monitor and reduce concentration if irritation is excessive.

Local inflammatory response

Transient increase in local inflammation including mild swelling and erythema around the treated area as immune cells are recruited via FPR2/ALX receptor activation.

Management: This is expected and generally beneficial — indicates immune cell recruitment to the infection site. Monitor for excessive inflammation. Should resolve within 24-48 hours.

Mild wound exudate increase

Increased wound exudate in the first 24-48 hours of treatment as biofilm disruption releases bacterial contents and immune infiltration increases.

Management: Change wound dressings as needed. Increased exudate initially is expected with biofilm disruption. Should normalize within 2-3 days as bacterial load decreases.

Less Common

•Localized urticaria

•Transient pain at injection site

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

×Severe or worsening side effects that don't improve with dose adjustment or supportive care

×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing

×Your healthcare provider recommends discontinuation based on your clinical response

×Development of any new medical condition that may be contraindicated with Cathelicidin (hCAP-18 / Synthetic Derivatives)

×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)

×Abnormal lab results or clinical markers that suggest adverse effects

Cathelicidin (hCAP-18 / Synthetic Derivatives) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

✓May be used together under medical guidance.

With medications

!High concentrations of divalent cations (Mg²⁺, Ca²⁺) in formulations — may reduce electrostatic membrane binding of cationic cathelicidin peptides - Use with caution—discuss with your healthcare provider.

!Anionic surfactants or high-concentration albumin solutions — may sequester cationic peptides and reduce bioavailability - Use with caution—discuss with your healthcare provider.

!Immunosuppressive medications without supervision — cathelicidin derivatives promote immune activation that may conflict with immunosuppressive goals - Use with caution—discuss with your healthcare provider.

With supplements

✓Multivitamins - Generally safe to take alongside Cathelicidin (hCAP-18 / Synthetic Derivatives). Space doses apart if taking oral formulations to ensure optimal absorption.

✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Want the Full Picture?

View the complete Cathelicidin (hCAP-18 / Synthetic Derivatives) research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.